AHB
ABBV icon

Abner Herrman & Brock’s AbbVie ABBV Stock Holding History

Abner Herrman & Brock’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$633K Sell
2,515
-258
-9% -$55.5K 0.06% 62
2026
Q1 		$603K Sell
2,773
-314
-10% -$69.7K 0.07% 62
2025
Q4 		$705K Sell
3,087
-814
-21% -$185K 0.07% 63
2025
Q3 		$903K Buy
+3,901
New +$794K 0.09% 59
2024
Q4 		– Sell
-4,177
Closed -$825K – 53
2024
Q3 		$825K Hold
4,177
– – 0.1% 59
2024
Q2 		$717K Buy
4,177
+88
+2% +$14.6K 0.09% 60
2024
Q1 		$745K Buy
4,089
+55
+1% +$9.48K 0.09% 60
2023
Q4 		$625K Sell
4,034
-367
-8% -$53.5K 0.09% 63
2023
Q3 		$656K Sell
4,401
-458
-9% -$67.2K 0.1% 62
2023
Q2 		$655K Sell
4,859
-1,375
-22% -$202K 0.1% 63
2023
Q1 		$994K Buy
6,234
+5
+0.1% +$764 0.15% 58
2022
Q4 		$1.01M Sell
6,229
-50
-0.8% -$7.67K 0.15% 53
2022
Q3 		$843K Sell
6,279
-31
-0.5% -$4.45K 0.15% 52
2022
Q2 		$966K Buy
6,310
+1,608
+34% +$246K 0.17% 51
2022
Q1 		$762K Sell
4,702
-85
-2% -$12.3K 0.11% 57
2021
Q4 		$648K Buy
4,787
+473
+11% +$55.9K 0.08% 65
2021
Q3 		$465K Buy
4,314
+45
+1% +$5.14K 0.07% 69
2021
Q2 		$481K Sell
4,269
-410
-9% -$46.2K 0.07% 66
2021
Q1 		$506K Sell
4,679
-3,171
-40% -$339K 0.08% 68
2020
Q4 		$841K Sell
7,850
-50
-0.6% -$4.8K 0.13% 58
2020
Q3 		$692K Hold
7,900
– – 0.12% 60
2020
Q2 		$776K Buy
7,900
+71
+0.9% +$6.25K 0.14% 61
2020
Q1 		$596K Sell
7,829
-700
-8% -$59.6K 0.14% 56
2019
Q4 		$755K Buy
8,529
+1,500
+21% +$125K 0.11% 65
2019
Q3 		$532K Sell
7,029
-5,550
-44% -$381K 0.08% 75
2019
Q2 		$915K Buy
12,579
+5,450
+76% +$428K 0.13% 63
2019
Q1 		$575K Buy
7,129
+182
+3% +$14.9K 0.09% 70
2018
Q4 		$640K Buy
6,947
+544
+8% +$47.8K 0.12% 63
2018
Q3 		$606K Sell
6,403
-115
-2% -$10.9K 0.09% 76
2018
Q2 		$604K Sell
6,518
-75
-1% -$7.33K 0.09% 78
2018
Q1 		$624K Hold
6,593
– – 0.1% 79
2017
Q4 		$638K Hold
6,593
– – 0.11% 80
2017
Q3 		$586K Buy
6,593
+300
+5% +$22.8K 0.1% 83
2017
Q2 		$456K Buy
6,293
+18
+0.3% +$1.21K 0.09% 92
2017
Q1 		$409K Sell
6,275
-3,375
-35% -$212K 0.08% 91
2016
Q4 		$615K Sell
9,650
-88,856
-90% -$5.42M 0.13% 73
2016
Q3 		$6.21M Sell
98,506
-2,981
-3% -$193K 1.41% 33
2016
Q2 		$6.53M Sell
101,487
-4,434
-4% -$270K 1.52% 29
2016
Q1 		$6.05M Buy
105,921
+57,901
+121% +$3.23M 1.52% 32
2015
Q4 		$2.85M Buy
48,020
+14
+0% +$806 1.47% 26
2015
Q3 		$2.67M Buy
48,006
+215
+0.4% +$14K 1.43% 27
2015
Q2 		$3.25M Buy
47,791
+131
+0.3% +$8.55K 1.63% 24
2015
Q1 		$2.79M Sell
47,660
-750
-2% -$45.3K 1.42% 26
2014
Q4 		$3.17M Sell
48,410
-47,399
-49% -$2.99M 1.61% 27
2014
Q3 		$5.53M Buy
95,809
+7,745
+9% +$430K 1.63% 24
2014
Q2 		$4.97M Buy
88,064
+4,070
+5% +$214K 1.5% 31
2014
Q1 		$4.32M Buy
83,994
+34,194
+69% +$1.73M 1.38% 32
2013
Q4 		$2.51M Buy
49,800
+19,305
+63% +$949K 0.89% 43
2013
Q3 		$1.36M Sell
30,495
-20,150
-40% -$893K 0.91% 41
2013
Q2 		$2.09M Buy
+50,645
New +$2.21M 0.89% 47

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Abner Herrman & Brock's ABBV Position: Q2 2026 in Review

Abner Herrman & Brock reduced its AbbVie (ABBV) stake by 9.3% in Q2 2026, selling an estimated $55.5K and leaving 2,515 shares worth $633K. The position accounts for 0.06% of the portfolio, ranked #62.

Abner Herrman & Brock first reported a position in ABBV in Q2 2013 and has held it in 50 quarters since. The position peaked at $6.53M in Q2 2016. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Abner Herrman & Brock held 2,515 shares of AbbVie worth $633K as of Q2 2026.
  • Abner Herrman & Brock sold 258 AbbVie shares in Q2 2026, an estimated $55.5K.
  • AbbVie made up 0.06% of Abner Herrman & Brock's portfolio in Q2 2026, its #62 holding.
  • Abner Herrman & Brock first reported a position in AbbVie in Q2 2013 and has held it in 50 quarters since.
  • Abner Herrman & Brock's AbbVie position peaked at $6.53M in Q2 2016.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Abner Herrman & Brock's 13F filing for Q2 2026, filed 8 Jul 2026.